Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer

Michael L. Maitland, Matthew R. Levine, Mario E. Lacouture, Kristen E. Wroblewski, Christine H. Chung, Ilyssa O. Gordon, Livia Szeto, Gail Ratko, Keyoumars Soltani, Mark F. Kozloff, Philip C. Hoffman, Ravi Salgia, David P. Carbone, Theodore G. Karrison, Everett E. Vokes

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences